-
Date: October 27, 2010Roundtable ID: CV2166Citation: Med Roundtable Cardiovasc Ed. ; 1(4): 267 - 275.
The JNC 8---What Might Be Expected?
Moderator:
There is no moderator for this particular article.
Discussants:
There are no discussants for this particular article.
-
Summary:
Dr. Marvin Moser from the Yale School of Medicine moderated the topic "The JNC 8 - What Might Be Expected?" with Drs. Jan Basile from the Medical University of South Carolina, Norman Kaplan from UT Southwestern Medical School at Dallas, and Ronald Victor from Cedars-Sinai Medical Center, Los Angeles participating.
- The discussion focused primarily on:
- (1) Joint National Committee (JNC) reports prior to the forthcoming JNC 8,
- (2) progress in controlling hypertension, including special populations
- (3) blood pressure goals,
- (4) diagnostic evaluation of the hypertensive patient,
- (5) lifestyle changes that impact blood pressure,
- (6) initial therapy, including the use of beta-blockers and direct renin inhibitors, including eldery and obese populations,
- (7) combination therapy,
- (8) safety of ARBs and cancer, and
- (9) predictions on the recommendations that might be included in the forthcoming JNC 8 report.
- (Med Roundtable Cardiovasc Ed. 2010;1(4):267-275) ©2010 FoxP2 Media, LLC
-
Compounds:Trials:
ACCOMPLISH, ASCOT, DASH, HYVET, LIFE, MRC, NHANES, PREMIER, SHEP, STICH
Please subscribe to use our print features or to download PDF files.